Description
Overview
Introducing Gliptanza-Met 50-500 mg Film Coated Tablets, a premium pharmaceutical solution meticulously crafted by Boston Pharmaceutical Industries, an Egyptian manufacturer adhering to the highest GMP (Good Manufacturing Practice) standards. Engineered with precision, this innovative formulation combines the efficacy of Sitagliptin (Gliptan) and Metformin to deliver unparalleled support for blood glucose management. As part of our “Quality Beyond Seven Stars” brand commitment, Gliptanza-Met is designed to meet the rigorous demands of modern healthcare, ensuring safety, consistency, and superior performance in every dose.
Key Ingredients
Our Gliptanza-Met 50-500 mg tablets are formulated with premium-quality active and inactive ingredients, including:
- Sitagliptin (Gliptan): A DPP-4 inhibitor that enhances the body’s natural ability to regulate blood sugar levels, reducing glucose production in the liver and improving insulin secretion.
- Metformin: A well-established antidiabetic medication that helps lower blood glucose levels by improving insulin sensitivity and reducing hepatic glucose production.
- Film Coating Technology: Ensures easy swallowing, extended shelf life, and protection of the active ingredients for optimal efficacy.
- Pharmaceutical-Grade Excipients: Selected for purity and compatibility, adhering to Egyptian GMP and international quality standards.
Benefits
Experience the Boston Pharma difference with Gliptanza-Met, a product developed under our “Quality Beyond Seven Stars” ethos:
- Dual-Action Formula: Combines the glucose-lowering benefits of Sitagliptin and Metformin for comprehensive blood sugar control.
- GMP-Certified Manufacturing: Produced in state-of-the-art Egyptian facilities, ensuring adherence to global pharmaceutical quality benchmarks.
- Convenient Dosage: Film-coated tablets for easy administration, with strengths ranging from 50 mg to 500 mg to suit individual therapeutic needs.
- Proven Efficacy: Clinically validated to support long-term glucose management, reducing the risk of complications associated with diabetes.
- Premium Quality Assurance: Rigorous testing at every stage guarantees potency, purity, and consistency in every batch.
Who It’s For
Gliptanza-Met 50-500 mg is specifically formulated for adults requiring dual therapy for type 2 diabetes, particularly those who:
- Have been diagnosed with type 2 diabetes and require combined DPP-4 inhibition and biguanide therapy.
- Seek a high-quality, GMP-certified pharmaceutical solution to manage blood glucose levels effectively.
- Prefer a convenient, film-coated tablet format for improved compliance and ease of use.
- Prioritize products manufactured under Boston Pharma’s “Quality Beyond Seven Stars” standard.
Why Choose Boston Pharma
When it comes to pharmaceutical excellence, Boston Pharmaceutical Industries stands apart. Here’s why Gliptanza-Met is the trusted choice for healthcare professionals and patients alike:
- Egyptian GMP Certification: Our manufacturing facilities meet the highest international quality standards, ensuring your safety and peace of mind.
- “Quality Beyond Seven Stars”: A commitment to excellence that extends beyond regulatory compliance, incorporating cutting-edge technology and ethical practices.
- Clinical Expertise: Developed in collaboration with leading endocrinologists to deliver a product backed by scientific rigor and real-world efficacy.
- Global Trust: Recognized for reliability in over 60 countries, Boston Pharma is synonymous with premium pharmaceutical innovation.
- Patient-Centric Design: From dosage flexibility to patient-friendly formulations, we prioritize your comfort and therapeutic success.
Elevate your diabetes management regimen with Gliptanza-Met 50-500 mg—where quality meets compassion, and innovation meets reliability.
